Healthcare - Biotechnology - NASDAQ - US
$ 6.32
-7.2 %
$ 106 M
Market Cap
-9.72
P/E
INCOME STATEMENT
6 M
REVENUE
-7.9 M
OPERATING INCOME
-7.99 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Coya Therapeutics, Inc.
| Revenue | 6 M |
| Cost Of Revenue | 5.5 M |
| Gross Profit | 501 K |
| Operating Expenses | 13.9 M |
| Operating Income | -7.9 M |
| Other Expenses | 84.5 K |
| Net Income | -7.99 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 6.0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 5.5 | 27.4 K | 16.1 K | 0 |
| Gross Profit | 0.5 | 27.4 K | 16.1 K | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 13.9 | 9.8 | 4.9 | 0.7 |
| Selling, General and Administrative Expenses | 7.8 | 4.8 | 2.3 | 0.4 |
| Research and Development Expenses | 5.5 | 4.9 | 2.5 | 0.2 |
| Operating Income | (7.9) | (9.8) | (4.9) | (0.7) |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 0 | 2.4 | 0 | 39 K |
| Total Other Income | 0.6 | (2.4) | 21.5 K | 38.4 K |
| Pre-Tax Income | (7.3) | (12.2) | (4.9) | (0.7) |
| NET INCOME | ||||
| Tax Provision | 0.7 | 2.4 | 21.5 K | 705 |
| Net Income | (8.0) | (14.7) | (4.9) | (0.7) |
| EPS | 0.79 | 1.48 | 0.5 | 0.0757 |